Trademark: 90340401
Status Date
Thursday, January 26, 2023
Filing Date
Tuesday, November 24, 2020
Published for Opposition
Tuesday, December 28, 2021
Abandoned Date
Wednesday, January 25, 2023
5 Pharmaceutical preparations for human use used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments; biologic preparations for medical and therapeutic purposes used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments
44 Providing health and medical information; providing medical and health information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; all of the foregoing used for the treatment of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders, excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and antiaging and anti-wrinkle skin care prevention preparations and treatments
42 Scientific and technological services and research and design relating thereto in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical, biomedical and biological therapeutic research services in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; research in the fields of pharmaceutical and biologic therapeutic preparations, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; pharmaceutical research and development in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; providing scientific research information in the fields of pharmaceuticals, biomedicine, clinical trials and post-market trials in the field of central nervous system and other neurological diseases and disorders, metabolic diseases and disorders, ocular diseases and disorders and cardiovascular diseases and disorders; all of the foregoing excluding non-medicated cosmetic preparations, preparations for the treatment of skin-related diseases and disorders, and anti-aging and anti-wrinkle skin care prevention preparations and treatments
Jan 26, 2023
Abandonment Notice E-Mailed - After Publication
Jan 26, 2023
Abandonment - After Publication
Jan 25, 2023
Teas Express Abandonment Received
Aug 23, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 19, 2022
Sou Extension 1 Granted
Aug 19, 2022
Sou Extension 1 Filed
Aug 19, 2022
Teas Extension Received
Feb 22, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 1, 2022
Review Of Correspondence Complete
Feb 1, 2022
Changes/Corrections After Pub Approval Entered
Jan 31, 2022
Assigned To Petition Staff
Jan 20, 2022
Teas Post Publication Amendment Received
Jan 19, 2022
Teas Post Publication Amendment Received
Dec 28, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 28, 2021
Published For Opposition
Dec 8, 2021
Notification Of Notice Of Publication E-Mailed
Nov 22, 2021
Electronic Record Review Complete
Nov 19, 2021
On Hold - Electronic Record Review Required
Nov 17, 2021
Approved For Pub - Principal Register
Nov 11, 2021
Teas/Email Correspondence Entered
Nov 10, 2021
Correspondence Received In Law Office
Nov 10, 2021
Teas Response To Office Action Received
May 12, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
May 12, 2021
Teas Change Of Correspondence Received
May 12, 2021
Teas Change Of Owner Address Received
May 10, 2021
Notification Of Non-Final Action E-Mailed
May 10, 2021
Non-Final Action E-Mailed
May 10, 2021
Non-Final Action Written
May 8, 2021
Assigned To Examiner
Jan 30, 2021
New Application Office Supplied Data Entered
Nov 27, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
